Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years old or older
- You must have been attending a liver screening program for at least 6 months at a specialist liver centre
- You must have cirrhosis (scarring of the liver) confirmed either by a biopsy or by other accepted medical tests
- A recent scan (within the last 3 months) must have shown no signs of liver cancer
- Your liver must be visible and assessable using an ultrasound scan
- Your liver function must be at a level called Child-Pugh A or B, meaning it is not severely impaired (confirm with trial site)
- Your cirrhosis must be caused by a non-viral condition, or by hepatitis B or C that has been successfully treated or controlled
- Your estimated yearly risk of developing liver cancer must be greater than 3%
- You must be willing to sign a consent form agreeing to take part
- You must be covered by a social security/health insurance system (this appears to be a French healthcare requirement — confirm with trial site)
Who may not be able to join:
- People whose liver function is at the most severe level, called Child-Pugh C
- People with currently active hepatitis B or C infection
- People whose estimated yearly risk of developing liver cancer is less than 3%
- People who have not previously been enrolled in a liver cancer screening programme
- People who cannot have a Fast-MRI scan for any medical reason
- People whose liver cannot be seen clearly enough on an ultrasound scan
- People who are currently in prison or do not have freedom of movement
- People who are under legal guardianship or protection
- Women who are pregnant or breastfeeding
- People receiving a specific type of state medical aid called AME (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pierre NAHON, MD, PhD, Assistance Publique Hôpitaux de Paris (AP-HP)
Phone: 1 48 02 62 80
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incremental cost / QALY ratio
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.